Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Current Drug Targets
|
September 4, 2014
Complementary therapies in inflammatory bowel diseases
Philip Esters, Axel Dignass
Expert Opinion on Pharmacotherapy
|
March 21, 2024
Upadacitinib in Crohn's disease
Axel Dignass, Philip Esters, Cathrin Flauaus
Der Internist
|
January 17, 2022
[Biologics in inflammatory bowel diseases]
Philip Esters, Christopher Hackenberg, Herrmann Schulze, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
August 28, 2010
Accuracy of cardiovascular magnetic resonance in myocarditis: comparison of MR and histological findings in an animal model
Huedayi Korkusuz, Philip Esters, Frank Huebner, et al.
Scandinavian Journal of Gastroenterology
|
March 22, 2018
A prospective cohort study to assess the relevance of vedolizumab drug level monitoring in IBD patients
Hermann Schulze, Philip Esters, Franz Hartmann, et al.
United European Gastroenterology Journal
|
June 26, 2020
Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn's disease
Wolfgang Alexander Seeger, Juliane Thieringer, Philip Esters, et al.
The International Journal of Cardiovascular Imaging
|
February 14, 2012
Correlation of left ventricular wall thickness, heart mass, serological parameters and late gadolinium enhancement in cardiovascular magnetic resonance imaging of myocardial inflammation in an experimental animal model of autoimmune myocarditis
Wolfgang Kromen, Huedayi Korkusuz, Yuecel Korkusuz, et al.
European Radiology
|
May 22, 2009
Acute myocarditis in a rat model: late gadolinium enhancement with histopathological correlation
Huedayi Korkusuz, Philip Esters, Nagy Naguib, et al.
Therapeutic Advances in Gastroenterology
|
July 2, 2026
International collaborative experiences in managing pyoderma gangrenosum in patients with inflammatory bowel disease
Jan Guse, Andreas Blesl, Philip Esters, et al.
Zeitschrift Fur Gastroenterologie
|
December 1, 2020
Torsten Kucharzik, Axel U Dignass, Raja Atreya, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Current Drug Targets
|
September 4, 2014
Complementary therapies in inflammatory bowel diseases
Philip Esters, Axel Dignass
Expert Opinion on Pharmacotherapy
|
March 21, 2024
Upadacitinib in Crohn's disease
Axel Dignass, Philip Esters, Cathrin Flauaus
Der Internist
|
January 17, 2022
[Biologics in inflammatory bowel diseases]
Philip Esters, Christopher Hackenberg, Herrmann Schulze, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
August 28, 2010
Accuracy of cardiovascular magnetic resonance in myocarditis: comparison of MR and histological findings in an animal model
Huedayi Korkusuz, Philip Esters, Frank Huebner, et al.
Scandinavian Journal of Gastroenterology
|
March 22, 2018
A prospective cohort study to assess the relevance of vedolizumab drug level monitoring in IBD patients
Hermann Schulze, Philip Esters, Franz Hartmann, et al.
United European Gastroenterology Journal
|
June 26, 2020
Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn's disease
Wolfgang Alexander Seeger, Juliane Thieringer, Philip Esters, et al.
The International Journal of Cardiovascular Imaging
|
February 14, 2012
Correlation of left ventricular wall thickness, heart mass, serological parameters and late gadolinium enhancement in cardiovascular magnetic resonance imaging of myocardial inflammation in an experimental animal model of autoimmune myocarditis
Wolfgang Kromen, Huedayi Korkusuz, Yuecel Korkusuz, et al.
European Radiology
|
May 22, 2009
Acute myocarditis in a rat model: late gadolinium enhancement with histopathological correlation
Huedayi Korkusuz, Philip Esters, Nagy Naguib, et al.
Therapeutic Advances in Gastroenterology
|
July 2, 2026
International collaborative experiences in managing pyoderma gangrenosum in patients with inflammatory bowel disease
Jan Guse, Andreas Blesl, Philip Esters, et al.
Zeitschrift Fur Gastroenterologie
|
December 1, 2020
Torsten Kucharzik, Axel U Dignass, Raja Atreya, et al.
Page
of 2